More than 3000 ventilators have been delivered to the federal government from Australian manufacturer ResMed to assist the response to the COVID-19 pandemic.
It represents more than half of the 5500 ventilators
Read More
ResMed’s new product gets US FDA clearance
The United States Food and Drug Administration has cleared ResMed’s new AirMini sleep apnea treatment product.
Read More
Read More
Outsourcing credited for saving Blundstone
Blundstone CEO Steve Gunn has cited the controversial 2007 decision to offshore as a factor in saving the company.
Read More
Read More
ResMed speaks out against R&D tax incentive cuts
Australian medical devices company ResMed has spoken out against the rumoured cuts to the R&D tax incentive.
Read More
Read More